Hyro is an artificial intelligence startup developing an AI-powered administrative assistant for the healthcare industry.
The AI company’s software is designed to automate highly repetitive tasks prevalent in hospitals and doctor’s offices. These include scheduling appointments, filling prescriptions, and searching through physician directories.
Hyro just announced a $20 million raise in a Series B round led by Liberty Mutual, Macquarie Capital, and Black Opal. The latest fundraising round brings Hyro’s total valuation to $35 million.
Lending a Hand
The healthcare industry has experienced significant staffing issues since the start of the pandemic. By some estimates, almost 90% of medical practices struggled to find front-of-office staff over the past year. And others say the healthcare field has lost some 20% of its workforce.
Hyro’s tech isn’t intended to replace healthcare workers. It simply aims to make existing employees’ jobs easier by automating monotonous tasks. The AI tool essentially acts as a first line of defense by fielding incoming requests and determining whether to forward them to a human, direct the customer to relevant resources, or complete the task itself.
With this new raise, Hyro plans to continue investing in its tool and ramp up spending on its marketing and sales efforts.
AI’s Growing Role
The concept of using AI technology for customer service is nothing new. In fact, there are many existing companies purporting to offer a similar service to Hyro’s.
But if you’ve ever been met with a robocaller while attempting to contact customer service, you know automating consumer-facing roles isn’t always a step up. Hyro is betting AI is the missing link needed to take the technology to the next level.
If Hyro’s solution becomes widespread, you might reschedule your next doctor’s appointment with a robot. If the solution works as intended, you might not even realize it.
Looking for more stories like this? Check out On the Money — SoFi’s one-stop-shop for news, trends, and tips!
Please understand that this information provided is general in nature and shouldn’t be construed as a recommendation or solicitation of any products offered by SoFi’s affiliates and subsidiaries. In addition, this information is by no means meant to provide investment or financial advice, nor is it intended to serve as the basis for any investment decision or recommendation to buy or sell any asset. Keep in mind that investing involves risk, and past performance of an asset never guarantees future results or returns. It’s important for investors to consider their specific financial needs, goals, and risk profile before making an investment decision.
The information and analysis provided through hyperlinks to third party websites, while believed to be accurate, cannot be guaranteed by SoFi. These links are provided for informational purposes and should not be viewed as an endorsement. No brands or products mentioned are affiliated with SoFi, nor do they endorse or sponsor this content.
Communication of SoFi Wealth LLC an SEC Registered Investment Advisor
SoFi isn’t recommending and is not affiliated with the brands or companies displayed. Brands displayed neither endorse or sponsor this article. Third party trademarks and service marks referenced are property of their respective owners.